Scientific Advisory Board

  • Dr Jean-Frederic Sauniere - MD, PhD
    More

    Dr Jean-Frederic Sauniere

    MD, PhD

    Dr Jean-Frédéric Sauniere is currently medical oncologist at the Institut Paoli & Calmettes (“IPC”) in Marseille, France where he coordinates the translational research and early clinical research activities of the Institute. His role also involves patent filing and partnerships with academics and pharmaceutical companies.  His expertise is in medical oncology and pharmacology.

  • Dr Richard Harbottle - PHD
    More

    Dr Richard Harbottle

    PHD

    Dr Richard Harbottle is currently the Group Leader of Gene Therapy Research in the section of Molecular Medicine at Imperial College London. His research focuses on the development of DNA technologies for gene therapy, with a particular focus on the application of scaffold/matrix attachment region (S/MAR) vectors. His group utilises state-of-the-art techniques in molecular and cellular biology and bio-imaging with an emphasis in gene delivery to pre-clinical model systems. A particular focus of his group is the development of genetically marked tumour models, which can be used to investigate the molecular mechanisms of tumour formation as well as simplifying the validation of therapeutic intervention.

  • Professor Hilary Calvert - PHD
    More

    Professor Hilary Calvert

    PHD

    Professor Calvert, who has recently been appointed Director of Cancer Drug Discovery and Development at the UCL Cancer Institute, is internationally known among medical oncologists for his seminal work on chemotherapy and the development of the Calvert formula, which has benefited countless patients around the world.